Latest Breaking News On - Zivo bioscience inc - Page 1 : vimarsana.com

ZIVO BIOS : Quarterly Results (Excel) - MarketScreener

ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study

Reduction in intestinal damage enables poultry farms to optimize feed utilization ...

Zivo Bioscience Inc. (ZIVO) Reports Additional Findings from 42-Day Coccidiosis Challenge Study

ZIVO Bioscience Announces Uplisting to OTCQB Market

Zivo Bioscience, Inc. , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces it has...

ZIVO Bioscience Announces Uplisting to OTCQB Market

$2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying - OceanFirst Financial (NASDAQ:OCFC), Keurig Dr Pepper (NASDAQ:KDP)

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens

Zivo Bioscience, Inc. , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces the...

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) Sees Significant Growth in Short Interest

ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) saw a significant increase in short interest in October. As of October 15th, there was short interest totalling 161,300 shares, an increase of 109.8% from the September 30th total of 76,900 shares. Currently, 2.1% of the company’s stock are short sold. Based on an average daily trading […]

ZIVO Bioscience Announces Reverse Stock Split

Zivo Bioscience, Inc. , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced...

Short Interest in ZIVO Bioscience, Inc. (NASDAQ:ZIVO) Increases By 43.5%

ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 76,900 shares, an increase of 43.5% from the September 15th total of 53,600 shares. Based on an average daily volume of 14,800 shares, […]